Trials / Not Yet Recruiting
Not Yet RecruitingNCT07507422
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable SCS Therapy (PERSIST) Addendum - Inceptiv™ Spinal Cord Stimulation (SCS) Therapy
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 970 (estimated)
- Sponsor
- Medtronic · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The PERSIST study is being conducted within Medtronic's active post-market surveillance platform, the Product Surveillance Registry (PSR). The purpose of PERSIST is to generate long-term evidence for the Inceptiv™ Spinal Cord Stimulation therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Commercially available Inceptiv™ neurostimulation systems | Spinal cord stimulation therapy delivered during trialing and following implant of commercially available Inceptiv™ neurostimulation systems |
Timeline
- Start date
- 2026-04-17
- Primary completion
- 2029-06-27
- Completion
- 2034-01-11
- First posted
- 2026-04-02
- Last updated
- 2026-04-02
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07507422. Inclusion in this directory is not an endorsement.